Recognizing and managing comorbidities in psoriatic arthritis.

Area of Science:

• Rheumatology
• Dermatology
• Internal Medicine

Background:

• Psoriatic arthritis (PsA) is a chronic inflammatory condition often accompanied by other health issues.
• These comorbidities significantly influence patient morbidity and mortality.
• A comprehensive understanding of these associations is vital for optimal patient care.

Purpose of the Study:

• To review and synthesize current evidence on medical comorbidities in PsA patients.
• To explore the impact of comorbidities on PsA prognosis.
• To examine how comorbidities influence the selection of therapies and treatment response in PsA.

Main Methods:

• Literature review of existing studies on PsA comorbidities.
• Analysis of data regarding the association between PsA and various medical conditions.
• Synthesis of findings related to prognosis, therapy selection, and treatment response.

Main Results:

• Common comorbidities include cardiovascular disease, metabolic syndrome, obesity, diabetes, and fatty liver disease.
• Other prevalent conditions are Crohn's disease, ophthalmic disease, depression, and anxiety.
• Increased risks for malignancy and osteoporosis are noted, though data are less consistent.

Conclusions:

• Clinicians managing PsA must recognize and understand associated comorbidities.
• Awareness of comorbidities is essential for informed management decisions.
• Addressing comorbidities is key to improving outcomes for patients with psoriatic arthritis.